[ad_1]
Investing.com – Collplant ADR reported on Thursday fourth quarter that missed analysts’ forecasts and income that fell in need of expectations.
Collplant ADR introduced earnings per share of $-0.40 on income of $109K. Analysts polled by Investing.com anticipated EPS of $-0.31 on income of $3.1M.
Collplant ADR shares are down 68.15% from the start of the yr and are buying and selling at $5.21 , down-from-52-week-high.
Collplant ADR follows different main Healthcare sector earnings this month
Collplant ADR’s report follows an earnings beat by AstraZeneca ADR on Thursday, November 10, 2022, who reported EPS of $1.67 on income of $10.98B, in comparison with forecasts EPS of $0.77 on income of $10.78B.
Amgen had beat expectations on Thursday, November 3, 2022 with third quarter EPS of $4.7 on income of $6.7B, in comparison with forecast for EPS of $4.44 on income of $6,561M.
Keep up-to-date on all the upcoming earnings stories by visiting Investing.com’s earnings calendar
[ad_2]
Source link